Endeavor

Drug Aims To Improve Transplant Success for Myelofibrosis Patients

Study shows giving patients fedratinib is safe and could help reduce chance of relapse

Moffitt Study Explores Key Risk Factors To Better Personalize CAR T-Cell Therapy

The study analyzed ide-cel to help physicians intervene and reduce toxicities in multiple myeloma patients

Drug Offers New Option for Patients With Rare Blood Disorders in ‘No Man’s Land’

Fedratinib is approved to treat myelofibrosis and could be effective in myelodysplastic/myeloproliferative neoplasms

Largest Comprehensive Study Compares Efficacy of CAR T Products for Multiple Myeloma

Cilta-cel demonstrates greater effectiveness than ide-cel but carries higher toxicities, study finds

Bolts Fight for a Cure at Hockey Fights Cancer Night

Tampa Bay Lightning game raises $30,000 for cancer research and patient services

Patients, Toddlers and Football Players

Tampa Bay Buccaneers Rookies visit Moffitt Cancer Center

Everyday Interactions, Extraordinary Impact: Moffitt McKinley Hospital Celebrates a Year of Serving Patients

A focus on outstanding care marks first year of memories at Moffitt McKinley Hospital

An Ambassador for the Gold Standard in Nursing

Moffitt achieves third Magnet designation, highlighting world-class nursing care

Paving the Way and Passing the Torch

Longtime Moffitt board member Celia Ferman recruits Ashley Bell Barnett to take her place